Kinalta Therapeutics
Business Services · New Jersey, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
103 Carnegie Ctr Ste 300, Princeton, New...Phone Number
(609) 580-0549Website
www.kinaltatx.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About Kinalta Therapeutics
Kinalta Therapeutics, Inc. is a US-based pharmaceutical company focused on developing innovative therapeutics for the Chinese market, particularly targeting unmet medical needs. The company specializes in identifying and licensing New Chemical Entities (NCE) and is committed to advancing these assets through preclinical and early clinical development stages. Their therapeutic areas of interest include liver disease, pulmonary disease, pain and inflammation, and kidney disease, with a strong emphasis on small molecules and synthetic peptides. Kinalta Therapeutics aims to achieve regulatory approval in China before expanding into global markets.Explore more
Popular SearchesKinalta Therapeutics IncKinalta TherapeuticsSIC Code 87,873NAICS Code 54,541Show more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Kinalta Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Kinalta Therapeutics
Funding: Get notified immidiatlly once Kinalta Therapeutics has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Kinalta Therapeutics launches new products
Click to see if Kinalta Therapeutics had a recent Job posting/layoffs
Check out if Kinalta Therapeutics is spiking on competitors!
Check if Kinalta Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Kinalta Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on Kinalta Therapeutics recently announced quarterly report
Recommended Actions
Reach out to Masked Content who joined Kinalta Therapeutics as Masked Content
Find more new buyers
Compare Similar Companies to Kinalta Therapeutics
Compare insights from companies similar to Kinalta Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Kinalta Therapeutics
<$5M
11-50
Private
-
-
N/A
Company Profile Activity
Activity Insights
Kinalta Therapeutics is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Kinalta Therapeutics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Kinalta Therapeutics.
Kinalta Therapeutics Tech Stack
A closer look at the technologies used by Kinalta Therapeutics
Top Business Services Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Kinalta Therapeutics
Sign Up For FreeTo access detailed company insights
Kinalta Therapeutics, Inc. is a US-based pharmaceutical company focused on developing innovative therapeutics for the Chinese market, particularly targeting unmet medical needs. The company specializes in identifying and licensing New Chemical Entities (NCE) and is committed to advancing these assets through preclinical and early clinical developme... Read More
